Inventor · Seattle, WA, US

John Latham

128Patents
22h-index
78Co-inventors
93Inventor score

Filing activity: Apr 28, 1994 → Jun 27, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US5582981A Method for identifying an oligonucleotide aptamer specific for a target Physics 241 Expired
US5756291A Aptamers specific for biomolecules and methods of making Chemistry; Metallurgy 190 Expired
US5840867A Aptamer analogs specific for biomolecules Chemistry; Metallurgy 129 Expired
US7935340B2 Antibodies to IL-6 and use thereof Chemistry; Metallurgy 82 Active
US7592429B2 Sclerostin-binding antibody Chemistry; Metallurgy 76 Expired
US7578999B2 Antibodies specific for sclerostin Physics 54 Active
US8323649B2 Antibodies to IL-6 and use thereof Emerging Cross-Sectional Technologies 54 Active
US7381409B2 Antibodies specific for sclerostin and methods of screening and use therefor Physics 53 Expired
US7906117B2 Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever Chemistry; Metallurgy 53 Active
US8062864B2 Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies Chemistry; Metallurgy 50 Active
US8268582B2 Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy Chemistry; Metallurgy 49 Active
US8178101B2 Use of anti-IL-6 antibodies having specific binding properties to treat cachexia Chemistry; Metallurgy 48 Active
US8337847B2 Methods of treating anemia using anti-IL-6 antibodies Emerging Cross-Sectional Technologies 48 Active
US7872106B2 Sclerostin-binding antibodies Chemistry; Metallurgy 47 Active
US7226902B2 Ligands for TGF-beta binding proteins and uses thereof Physics 44 Expired
US7868134B2 Immunogenic peptides derived from sclerostin Physics 42 Active
US8911734B2 Methods of preventing or treating pain using anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75 Emerging Cross-Sectional Technologies 38 Active
US9255154B2 Anti-PCSK9 antibodies and use thereof Physics 32 Active
US7927863B2 Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy Chemistry; Metallurgy 29 Active
US8728473B2 Methods of preventing or treating pain using anti-NGF antibodies Emerging Cross-Sectional Technologies 26 Active
US9085615B2 Antibodies to IL-6 to inhibit or treat inflammation Emerging Cross-Sectional Technologies 24 Active
US9452227B2 Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments Emerging Cross-Sectional Technologies 22 Active
US9745373B2 Anti-CGRP compositions and use thereof Chemistry; Metallurgy 18 Active
US9855332B2 Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with diseases or treatments that result in elevated CGRP levels Emerging Cross-Sectional Technologies 18 Active
US9708393B2 Use of anti-CGRP antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers Emerging Cross-Sectional Technologies 18 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.